Search

Author/Creator Lo, Kim Hung

2. AB0385 INTEGRATED SAFETY ANALYSIS ACROSS PHASE 3 CLINICAL STUDIES INCLUDING THE CONTROLLED AND UNCONTROLLED PERIODS FOR INTRAVENOUS GOLIMUMAB IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS. (June 2019)

Authors:
Deodhar, Atul; Elaine Husni, M; Schwartzman, Sergio; Kafka, Shelly; Chakravarty, Soumya D.; Hsia, Elizabeth C.; Harrison, Diane D.; Leu, Jocelyn H.; Zhou, Yiying; Lo, Kim Hung; Kavanaugh, Arthur
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
1653
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. AB0754 CLINICALLY MEANINGFUL IMPROVEMENT IN SKIN AND NAIL PSORIASIS IN BIO-NAÏVE ACTIVE PSORIATIC ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS GOLIMUMAB: RESULTS THROUGH WEEK 52 FROM A PHASE-3 STUDY. (June 2019)

Authors:
Elaine Husni, M; Mease, Philip J.; Chakravarty, Soumya D.; Kafka, Shelly; Harrison, Diane D.; Parenti, Dennis; Kim, Lilianne; Lo, Kim Hung; Hsia, Elizabeth C.; Kavanaugh, Arthur
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
1843
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study. Issue 5 (1st August 2022)

Authors:
Deodhar, Atul A.; Shiff, Natalie J.; Gong, Cinty; Hsia, Elizabeth C.; Lo, Kim Hung; Kim, Lilliane; Xu, Stephen; Reveille, John D.
Journal:
Journal of clinical rheumatology
Issue:
Volume 28:Issue 5(2022)
Page Start:
270
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study. Issue 8 (2nd December 2022)

Authors:
Deodhar, Atul; Chakravarty, Soumya D.; Shiff, Natalie J.; Lo, Kim Hung; Xu, Stephen; Hsia, Elizabeth C.; Danve, Abhijeet; Reveille, John D.
Journal:
Journal of clinical rheumatology
Issue:
Volume 28:Issue 8(2022)
Page Start:
420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and Safety of Intravenous Golimumab Through One Year in Patients With Active Psoriatic Arthritis. Issue 6 (15th May 2020)

Authors:
Husni, M. Elaine; Kavanaugh, Arthur; Murphy, Frederick; Rekalov, Dmytro; Harrison, Diane D.; Kim, Lilianne; Lo, Kim Hung; Leu, Jocelyn H.; Hsia, Elizabeth C.
Journal:
Arthritis care & research
Issue:
Volume 72:Issue 6(2020)
Page Start:
806
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial. Issue 12 (December 2015)

Authors:
Bingham, Clifton O.; Mendelsohn, Alan M.; Kim, Lilianne; Xu, Zhenhua; Leu, Jocelyn; Han, Chenglong; Lo, Kim Hung; Westhovens, Rene; Weinblatt, Michael E.
Journal:
Arthritis care & research
Issue:
Volume 67:Issue 12(2015:Dec.)
Page Start:
1627
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus. Issue 5 (1st April 2020)

Authors:
van Vollenhoven, Ronald F.; Hahn, Bevra H.; Tsokos, George C.; Lipsky, Peter; Fei, Kaiyin; Gordon, Robert M.; Gregan, Irene; Lo, Kim Hung; Chevrier, Marc; Rose, Shawn
Journal:
Arthritis & rheumatology
Issue:
Volume 72:Issue 5(2020)
Page Start:
761
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. OP0041 MAINTENANCE OF EFFICACY AND SAFETY AND REDUCTION OF BILAG FLARES WITH USTEKINUMAB, AN INTERLEUKIN-12/23 INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): 1-YEAR RESULTS OF A PHASE 2, RANDOMIZED PLACEBO-CONTROLLED, CROSSOVER STUDY. (June 2019)

Authors:
Vollenhoven, Ronald van; Tsokos, George; Gordon, Robert; Lo, Kim Hung; Irene Gregan, Y; Fei, Kaiyin; Rose, Shawn; Hahn, Bevra H.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis. (26th January 2021)

Authors:
Ruperto, Nicolino; Brunner, Hermine I; Pacheco-Tena, César; Louw, Ingrid; Vega-Cornejo, Gabriel; Spindler, Alberto J; Kingsbury, Daniel J; Schmeling, Heinrike; Borzutzky, Arturo; Cuttica, Rubén; Inman, C J; Malievskiy, Victor; Scott, Christiaan; Keltsev, Vladimir; Terreri, Maria Teresa; Viola, Di...
Journal:
Rheumatology
Issue:
Volume 60:Number 10(2021)
Page Start:
4495
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗